JP2007502684A5 - - Google Patents

Download PDF

Info

Publication number
JP2007502684A5
JP2007502684A5 JP2006530185A JP2006530185A JP2007502684A5 JP 2007502684 A5 JP2007502684 A5 JP 2007502684A5 JP 2006530185 A JP2006530185 A JP 2006530185A JP 2006530185 A JP2006530185 A JP 2006530185A JP 2007502684 A5 JP2007502684 A5 JP 2007502684A5
Authority
JP
Japan
Prior art keywords
container
container according
vial
pharmaceutical composition
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006530185A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007502684A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/050779 external-priority patent/WO2004100979A2/en
Publication of JP2007502684A publication Critical patent/JP2007502684A/ja
Publication of JP2007502684A5 publication Critical patent/JP2007502684A5/ja
Withdrawn legal-status Critical Current

Links

JP2006530185A 2003-05-13 2004-05-12 医薬容器内の安定化した液体タンパク質の処方物(formulation) Withdrawn JP2007502684A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03010671 2003-05-13
PCT/EP2004/050779 WO2004100979A2 (en) 2003-05-13 2004-05-12 Liquid stabilized protein formulations in coated pharmaceutical containers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012005485A Division JP2012096063A (ja) 2003-05-13 2012-01-13 医薬容器内の安定化した液体タンパク質の処方物

Publications (2)

Publication Number Publication Date
JP2007502684A JP2007502684A (ja) 2007-02-15
JP2007502684A5 true JP2007502684A5 (cg-RX-API-DMAC7.html) 2012-03-08

Family

ID=33442722

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006530185A Withdrawn JP2007502684A (ja) 2003-05-13 2004-05-12 医薬容器内の安定化した液体タンパク質の処方物(formulation)
JP2012005485A Pending JP2012096063A (ja) 2003-05-13 2012-01-13 医薬容器内の安定化した液体タンパク質の処方物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012005485A Pending JP2012096063A (ja) 2003-05-13 2012-01-13 医薬容器内の安定化した液体タンパク質の処方物

Country Status (22)

Country Link
US (2) USRE43331E1 (cg-RX-API-DMAC7.html)
EP (2) EP2324845A1 (cg-RX-API-DMAC7.html)
JP (2) JP2007502684A (cg-RX-API-DMAC7.html)
KR (1) KR101084412B1 (cg-RX-API-DMAC7.html)
CN (1) CN1809376B (cg-RX-API-DMAC7.html)
AR (1) AR044302A1 (cg-RX-API-DMAC7.html)
AU (1) AU2004237982C1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0410679A (cg-RX-API-DMAC7.html)
CA (1) CA2523477A1 (cg-RX-API-DMAC7.html)
CY (1) CY1115233T1 (cg-RX-API-DMAC7.html)
DK (1) DK1633388T3 (cg-RX-API-DMAC7.html)
EA (1) EA008308B1 (cg-RX-API-DMAC7.html)
ES (1) ES2471942T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20140267T1 (cg-RX-API-DMAC7.html)
IL (1) IL171912A (cg-RX-API-DMAC7.html)
MX (1) MXPA05012191A (cg-RX-API-DMAC7.html)
NO (1) NO20055774D0 (cg-RX-API-DMAC7.html)
PL (1) PL1633388T3 (cg-RX-API-DMAC7.html)
PT (1) PT1633388E (cg-RX-API-DMAC7.html)
SI (1) SI1633388T1 (cg-RX-API-DMAC7.html)
UA (1) UA91493C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004100979A2 (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879320B2 (en) * 2004-05-17 2011-02-01 Ares Trading S.A. Hydrogel interferon formulations
US7731948B2 (en) * 2004-06-01 2010-06-08 Ares Trading S.A. Stabilized interferon liquid formulations
EP1845925B1 (en) 2005-01-12 2016-08-24 Biogen MA Inc. Method for delivering interferon-beta
CA2615731A1 (en) * 2005-07-29 2007-02-08 Amgen Inc. Formulations that inhibit protein aggregation
US20070253985A1 (en) * 2006-04-26 2007-11-01 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
KR100785070B1 (ko) 2006-07-11 2007-12-12 삼성전자주식회사 휴대 단말기에서 디지털 저작권 관리 콘텐츠 재생 방법 및장치
AU2008269086B2 (en) 2007-06-25 2014-06-12 Amgen Inc. Compositions of specific binding agents to hepatocyte growth factor
RS52417B (sr) * 2007-12-20 2013-02-28 Merck Serono S.A. Formulacije peg-interferona-beta
WO2010056804A1 (en) 2008-11-12 2010-05-20 Medimmune, Llc Antibody formulation
CN107095846A (zh) 2009-12-21 2017-08-29 霍夫曼-拉罗奇有限公司 抗体配制剂
US8802603B2 (en) 2010-06-17 2014-08-12 Becton, Dickinson And Company Medical components having coated surfaces exhibiting low friction and low reactivity
WO2012022734A2 (en) 2010-08-16 2012-02-23 Medimmune Limited Anti-icam-1 antibodies and methods of use
FR2966044B1 (fr) * 2010-10-18 2012-11-02 Sanofi Pasteur Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
CA2890933C (en) 2012-12-03 2021-06-08 Novobiotic Pharmaceuticals, Llc Novel depsipeptide and uses thereof
BR112015017307A2 (pt) 2013-03-14 2017-11-21 Abbvie Inc composições de espécies com baixa acidez e métodos para produção e uso das mesmas
WO2014159554A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. Low acidic species compositions and methods for producing the same using displacement chromatography
PT3613423T (pt) 2013-07-10 2022-12-07 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
WO2015050959A1 (en) 2013-10-01 2015-04-09 Yale University Anti-kit antibodies and methods of use thereof
JP6685897B2 (ja) * 2014-03-13 2020-04-22 ステヴァナト グループ インターナショナル エイ.エス. 液体製剤を処理する方法
US20170226552A1 (en) 2014-07-03 2017-08-10 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt
US20160185848A1 (en) 2014-07-09 2016-06-30 Abbvie Inc. Methods for modulating the glycosylation profile of recombinant proteins using sugars
WO2016144773A1 (en) 2015-03-06 2016-09-15 Abbvie Inc. Arabinosylated glycoproteins
WO2016163764A2 (ko) * 2015-04-07 2016-10-13 에이비온 주식회사 인터페론 베타 변이체의 안정화 제제
PT3352766T (pt) 2015-09-24 2022-03-22 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e processos para o seu uso
WO2017147003A1 (en) 2016-02-26 2017-08-31 Novobiotic Pharmaceuticals, Llc Novel macrocyclic antibiotics and uses thereof
FI126979B (en) 2016-02-29 2017-09-15 Faron Pharmaceuticals Oy Lyophilized pharmaceutical formulation and its use
ES2981759T3 (es) 2017-04-04 2024-10-10 Novobiotic Pharmaceuticals Llc Nuevos depsipéptidos y sus usos
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2622598A (en) 1951-03-08 1952-12-23 Premo Pharmaceutical Lab Inc Drain-clear container for aqueous liquid pharmaceutical preparations
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
JP3332379B2 (ja) 1992-05-06 2002-10-07 マリンクロッド・インコーポレイテッド 次亜塩素酸ナトリウム溶液の安定性保持用容器封鎖物システム
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
TW249202B (cg-RX-API-DMAC7.html) * 1993-08-13 1995-06-11 Ciba Gerigy Corp
TW426523B (en) * 1995-04-06 2001-03-21 Hoffmann La Roche Interferon solution
JP4057058B2 (ja) 1995-11-07 2008-03-05 ジェネンテック インコーポレーテッド Ngfの安定化処方
US6142977A (en) 1996-10-18 2000-11-07 Schering Ag Prefilled, sterilized syringe with a new and improved plug
DE69729880T3 (de) * 1996-12-24 2012-05-10 Biogen Idec Ma Inc. Stabile flüssige interferon-zubereitungen
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
CN2326243Y (zh) 1997-09-29 1999-06-30 程继勇 覆膜药用瓶塞
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
CN2441750Y (zh) * 2000-06-23 2001-08-08 程继勇 表面覆膜药用橡胶瓶塞
JP2002209975A (ja) * 2001-01-19 2002-07-30 Daikyo Seiko Ltd 医薬バイアル用ラミネートゴム栓
CN1133565C (zh) * 2001-10-18 2004-01-07 郑秀娣 药品瓶塞隔离膜

Similar Documents

Publication Publication Date Title
HRP20140267T1 (hr) Tekuä†e stabilizirane formulacije interferona-beta u obloženim farmaceutskim spremnicima
FI3506886T3 (fi) Erittäin väkevöityjä alhaisen viskositeetin masp-2:ta estäviä vasta-aineformulaatioita, tarvikesarjoja ja menetelmiä
HRP20171894T1 (hr) Kombinacija inzulina i agonista glp-1
MX2021007393A (es) Formulacion de solucion de proteinas que contiene una alta concentracion de un anticuerpo anti-vegf.
CN109010803A (zh) 一种重组人干扰素α2b滴眼液及其制备方法
CN112004521A (zh) 用于递送胰岛素化合物的医用输注泵系统
DK2624865T3 (en) Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
WO2019193351A1 (en) Medical infusion pump system for the delivery of an insulin compound
JP6445169B2 (ja) α型インターフェロンを含有する安定したベンジルアルコールフリーの水溶液製剤
JP2001278788A (ja) アラントインを配合した安定な液剤
JPS61221125A (ja) ペプタイドの吸着防止組成物
WO2019176239A1 (ja) 容器充填ヒトpth(1-34)液体医薬組成物及びその製造方法
JP4707327B2 (ja) ポリペプタイド類の吸着防止剤
TH102367A (th) สูตรผสมอินเตอร์เฟียรอนที่เป็นของเหลวซึ่งถูกทำให้เสถียรโดยปลอด hsa
TH73258B (th) สูตรผสมอินเตอร์เฟียรอนที่เป็นของเหลวซึ่งถูกทำให้เสถียรโดยปลอด hsa
JPS60100524A (ja) ペプタイド吸着防止組成物および方法
JP2000290195A (ja) カルシトニン類のプレフィルドシリンジ製剤
HK1242218A1 (en) Stable, benzyl alcohol-free aqueous solution formulations containing alpha-type interferon
JPS5976024A (ja) インシユリン吸着防止組成物および方法